NCT06082635 2025-05-18TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)Shenzhen TargetRx Co., Ltd.Phase 3 Active not recruiting321 enrolled
NCT05561374 2024-11-29Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade GliomaOblato, Inc.Phase 1 Active not recruiting16 enrolled